Overview

TNF- Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.

Status:
NOT_YET_RECRUITING
Trial end date:
2028-10-31
Target enrollment:
Participant gender:
Summary
The investigators assessed the effect of TNF- antagonism within 6 hours of return of spontaneous circulation on 30-day mortality in patients who remained comatose after cardiopulmonary resuscitation (CPR) following cardiac arrest . In addition, the investigators explored the role of this treatment in modulating the systemic inflammatory response and its potential impact on 90- and 180-day morbidity and mortality and neurological outcomes.
Phase:
NA
Details
Lead Sponsor:
Peking University Third Hospital
Collaborators:
Hunan Provincial People's Hospital
Jiangsu Provincial People's Hospital
Peking University First Hospital
Peking University People's Hospital
Peking University Shenzhen Hospital
People's Hospital of Guangxi Zhuang Autonomous Region
People's Hospital of Xinjiang Uygur Autonomous Region
Qilu Hospital of Shandong University
Renmin Hospital of Wuhan University
Sichuan Provincial People's Hospital
Treatments:
Infliximab